Session 1: Opening Session by Lauren Kim (Founder, Program Director, and Webmaster of Diabetes Virtual Camp, University of Southern California, B.S. in Human Biology, 2024) and Allison Kim (Associate Director and Director of Outreach, Boston University, B.A. in Biology, 2023). Lauren and Allison welcome our program interns and discuss the program goals and objectives.
The Diabetes Virtual Summer Camp 2024 celebrated its 4-year anniversary and 7th program with today’s Session 1 - Opening Session where Lauren Kim and Allison Kim welcomed 537 interns from 40 countries around the world and shared the goals and objectives for the program. The Opening Session ended with many insightful questions from our interns. We are thrilled to meet the interns joining our virtual program from all around the world to better understand diabetes and inspire our next generation of physicians and scientists.

Session 1: Opening Session. Lauren Kim (Founder, Program Director, and Webmaster, University of Southern California, B.S. in Human Biology, 2024) welcomes our DVSC24 interns. Our program is joined by 537 interns from 40 countries and 35 states across the U.S. Our interns represent various demographics: 96 high school students, 130 college students, 31 post-undergraduate students, 10 pharmacy school students, 12 nutritionists/dieticians, 108 graduate students, 19 medical students, 12 medical residents, 17 clinical fellows, 43 postdoc and research fellows, 19 early-career clinicians/researchers, and 26 other health professionals, all representing over 270 institutions globally.

Session 1: Opening Session. Allison Kim (Associate Director and Director of Outreach, Boston University, B.A. in Biology, 2023) welcomes our DVSC24 interns. Our program is joined by interns from all around the world with diverse demographics. Sex: 151 men and 367 women. Age from 14 to 69: 14-17 (91), 18-25 (210), 26-35 (141), 36-45 (64), 46-55 (12), 56-65 (3), and 66-75 (2). Ethnicity: 75 African American or Black, 2 Native Hawaiian or Pacific Islander, 273 Asian or Asian American, 56 Hispanic, Latinx or Spanish Origin, 37 Middle Eastern or North African and 49 White.

Session 1: Opening Session. Dr. Jason Kim (Advisor) welcomes our DVSC24 interns. Our interns represent diverse demographics in education credentials: 148 interns with B.S. or .B.A., 60 interns with M.S., M.A., or M.P.H., 55 interns with M.D., 56 interns with Ph.D., 12 interns with M.D./Ph.D., and 44 interns with other degrees.

Session 1: Opening Session. Our interns from all around the world!

Session 1: Opening Session. Our interns from all around the world!

Session 1: Opening Session. Our interns from all around the world!

Session 1: Opening Sessions. The Diabetes Virtual Camp is supported in part by the American Diabetes Association and The Leona M. and Harry B. Helmsley Charitable Trust.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School)
The Expert Session kicked off with “Introduction to Diabetes” by Dr. Jason Kim. The Opening Session ended with many insightful questions from our interns. We are thrilled to meet the interns joining our virtual program from all around the world to better understand diabetes and inspire our next generation of physicians and scientists.

Session 2: Introduction to Diabetes by Dr. Jason Kim (Professor of Molecular Medicine, Director of Metabolic Disease Research Center, MD/PhD Admissions Committee, University of Massachusetts Chan Medical School). This session introduced the topic of diabetes: different types and diagnostic criteria of diabetes, characteristic features of type 1 and type 2 diabetes, diabetic complications, the importance of glucose homeostasis and how insulin regulates our glucose levels, and insulin resistance and its role in developing type 2 diabetes. The session further discussed how to prevent and manage type 2 diabetes using lifestyle modifications (healthy diet and exercise) and different drugs used to treat diabetes.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our program interns.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our program interns.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our program interns.

Session 2: Introduction to Diabetes by Dr. Jason Kim (Professor of Molecular Medicine, Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, Director of Metabolic Disease Research Center, MD/PhD Admissions Committee, University of Massachusetts Chan Medical School)

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session discussed the basics and pathogenesis of different types of diabetes, diagnostic criteria for the disease, the importance of glucose homeostasis and its regulation by insulin and glucagon, the endocrine role of the pancreas, the mechanism of insulin action and insulin signaling, molecular pathogenesis of insulin resistance, the role of diets and exercise in preventing and managing diabetes, pharmacological management of diabetes including recently approved diabetes drugs (e.g., semaglutide, tirzepatide), and our recent research on metabolic liver disease. Dr. Kim ended the session with an insightful question posed by the late Dr. Denis McGarry, “What if Minkowski had been ageusic?”, opening doors to the important notion that while diabetes is manifested by altered carbohydrate metabolism, diabetes is causally associated with altered fat metabolism.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session discussed the basics and pathogenesis of different types of diabetes, diagnostic criteria for the disease, the importance of glucose homeostasis and its regulation by insulin and glucagon, the endocrine role of the pancreas, the mechanism of insulin action and insulin signaling, molecular pathogenesis of insulin resistance, the role of diets and exercise in preventing and managing diabetes, pharmacological management of diabetes including recently approved diabetes drugs (e.g., semaglutide, tirzepatide), and our recent research on metabolic liver disease. Dr. Kim ended the session with an insightful question posed by the late Dr. Denis McGarry, “What if Minkowski had been ageusic?”, opening doors to the important notion that while diabetes is manifested by altered carbohydrate metabolism, diabetes is causally associated with altered fat metabolism.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session discussed the basics and pathogenesis of different types of diabetes, diagnostic criteria for the disease, the importance of glucose homeostasis and its regulation by insulin and glucagon, the endocrine role of the pancreas, the mechanism of insulin action and insulin signaling, molecular pathogenesis of insulin resistance, the role of diets and exercise in preventing and managing diabetes, pharmacological management of diabetes including recently approved diabetes drugs (e.g., semaglutide, tirzepatide), and our recent research on metabolic liver disease. Dr. Kim ended the session with an insightful question posed by the late Dr. Denis McGarry, “What if Minkowski had been ageusic?”, opening doors to the important notion that while diabetes is manifested by altered carbohydrate metabolism, diabetes is causally associated with altered fat metabolism.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). . This session discussed the basics and pathogenesis of different types of diabetes, diagnostic criteria for the disease, the importance of glucose homeostasis and its regulation by insulin and glucagon, the endocrine role of the pancreas, the mechanism of insulin action and insulin signaling, molecular pathogenesis of insulin resistance, the role of diets and exercise in preventing and managing diabetes, pharmacological management of diabetes including recently approved diabetes drugs (e.g., semaglutide, tirzepatide), and our recent research on metabolic liver disease. Dr. Kim ended the session with an insightful question posed by the late Dr. Denis McGarry, “What if Minkowski had been ageusic?”, opening doors to the important notion that while diabetes is manifested by altered carbohydrate metabolism, diabetes is causally associated with altered fat metabolism.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session discussed the basics and pathogenesis of different types of diabetes, diagnostic criteria for the disease, the importance of glucose homeostasis and its regulation by insulin and glucagon, the endocrine role of the pancreas, the mechanism of insulin action and insulin signaling, molecular pathogenesis of insulin resistance, the role of diets and exercise in preventing and managing diabetes, pharmacological management of diabetes including recently approved diabetes drugs (e.g., semaglutide, tirzepatide), and our recent research on metabolic liver disease. Dr. Kim ended the session with an insightful question posed by the late Dr. Denis McGarry, “What if Minkowski had been ageusic?”, opening doors to the important notion that while diabetes is manifested by altered carbohydrate metabolism, diabetes is causally associated with altered fat metabolism.

Session 2: Introduction to Diabetes by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses thoughtful questions from our interns.

Session 1-2: Open Mic Session by Dr. Jason Kim and DVC Team. Dr. Kim invites our interns to ask questions in an open mic forum.

Session 1-2: Opening Sessions. The Diabetes Virtual Camp is supported in-part by the American Diabetes Association and The Leona M. and Harry B. Helmsley Charitable Trust.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira welcomes our DVSC24 interns.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira first shared an inspiring story of his journey to becoming an impactful physician-scientist, beginning with his undergraduate thesis work at the University of Chicago that paved the way to his MD/PhD training at the University of Chicago , an across-the-country trip to San Francisco for his fellowship training at UCSF, and his thriving academic career that began at the University of Virginia leading to the Indiana University School of Medicine and his current leadership roles at the University of Chicago. He also shared some exciting findings from his research program on the role of polyamine metabolism in beta-cell stress and the therapeutic potential of DFMO (alpha-difluoromethylornithine) in treating type 1 diabetes (Cell Reports Medicine, Vol. 4, 101261, Nov. 21, 2023).

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (Professor of Medicine, Section of Endocrinology, Diabetes and Metabolism, Director of Translational Research Center, and Associate Vice Chair for Translational Research, The University of Chicago)

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira interacts with our DVSC24 interns.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira interacts with our DVSC24 interns.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira shared an inspiring story of his journey to becoming an impactful physician-scientist, beginning with his undergraduate thesis work at the University of Chicago that paved the way to his MD/PhD training at the University of Chicago , an across-the-country trip to San Francisco for his fellowship training at UCSF, and his thriving academic career that began at the University of Virginia leading to the Indiana University School of Medicine and his current leadership roles at the University of Chicago.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). He shared exciting findings from his research program on the role of polyamine metabolism in beta-cell stress and the therapeutic potential of DFMO (alpha-difluoromethylornithine) in treating type 1 diabetes (Cell Reports Medicine, Vol. 4, 101261, Nov. 21, 2023).

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). He shared exciting findings from his research program on the role of polyamine metabolism in beta-cell stress and the therapeutic potential of DFMO (alpha-difluoromethylornithine) in treating type 1 diabetes (Cell Reports Medicine, Vol. 4, 101261, Nov. 21, 2023).

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira interacts with our DVSC24 interns.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira interacts with our DVSC24 interns.

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago).

Session 3: A Career in Diabetes Research as a Physician-Scientist by Dr. Raghu Mirmira (University of Chicago). Dr. Mirmira addresses great question from our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin welcomes our DVSC24 interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Maren Laughlin shared various NIH programs to support scientists, clinicians, students, patients, and the general public. Dr. Laughlin discussed the role of the NIH and its structure, an overview of the grant funding mechanisms for investigator-initiated research, and training opportunities at the NIH campus in Bethesda and universities and medical schools for students, postdocs, and junior faculty. She also highlighted the important functions of the NIH in providing health information to the general public, disease-specific data for researchers and the public, and evolving communication tools. Dr. Laughlin ended the session with helpful information on “All of Us” Research Program that aims to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (Senior Advisor for Integrative Metabolism, Division of Diabetes, Endocrinology and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health)

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Maren Laughlin shared various NIH programs to support scientists, clinicians, students, patients, and the general public. Dr. Laughlin discussed the role of the NIH and its structure, an overview of the grant funding mechanisms for investigator-initiated research, and training opportunities at the NIH campus in Bethesda and universities and medical schools for students, postdocs, and junior faculty. She also highlighted the important functions of the NIH in providing health information to the general public, disease-specific data for researchers and the public, and evolving communication tools. Dr. Laughlin ended the session with helpful information on “All of Us” Research Program that aims to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Maren Laughlin shared various NIH programs to support scientists, clinicians, students, patients, and the general public. Dr. Laughlin discussed the role of the NIH and its structure, an overview of the grant funding mechanisms for investigator-initiated research, and training opportunities at the NIH campus in Bethesda and universities and medical schools for students, postdocs, and junior faculty. She also highlighted the important functions of the NIH in providing health information to the general public, disease-specific data for researchers and the public, and evolving communication tools. Dr. Laughlin ended the session with helpful information on “All of Us” Research Program that aims to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin interacts with our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin interacts with our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Maren Laughlin shared various NIH programs to support scientists, clinicians, students, patients, and the general public. Dr. Laughlin discussed the role of the NIH and its structure, an overview of the grant funding mechanisms for investigator-initiated research, and training opportunities at the NIH campus in Bethesda and universities and medical schools for students, postdocs, and junior faculty. She also highlighted the important functions of the NIH in providing health information to the general public, disease-specific data for researchers and the public, and evolving communication tools. Dr. Laughlin ended the session with helpful information on “All of Us” Research Program that aims to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Maren Laughlin shared various NIH programs to support scientists, clinicians, students, patients, and the general public. Dr. Laughlin discussed the role of the NIH and its structure, an overview of the grant funding mechanisms for investigator-initiated research, and training opportunities at the NIH campus in Bethesda and universities and medical schools for students, postdocs, and junior faculty. She also highlighted the important functions of the NIH in providing health information to the general public, disease-specific data for researchers and the public, and evolving communication tools. Dr. Laughlin ended the session with helpful information on “All of Us” Research Program that aims to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin interacts with our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin interacts with our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin addresses outstanding questions frow our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin addresses outstanding questions frow our interns.

Session 4: NIH Support for Diabetes Researchers and People with Diabetes by Dr. Maren Laughlin (National Institutes of Health). Dr. Laughlin addresses outstanding questions frow our interns.

Session 3-4: Open Mic Session by Dr. Jason Kim and Lauren Kim as interns are invited to ask questions in an open mic forum.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College)
Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine)
Dr. Laura Alonso and Dr. Carmella Evans-Molina welcome our DVSC24 interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College)
Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine)
Dr. Laura Alonso and Dr. Carmella Evans-Molina welcome our DVSC24 interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Laura Alonso welcomes our DVSC24 interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). As a physician-scientist studying ways to regenerate pancreatic beta cells to restore the body’s capacity to make insulin, I have the best job in the world. Each week I spend some of my time helping patients try to keep their diabetes under control using existing therapies, and the rest of my time leading a research laboratory seeking better treatments. In this session I’ll review the path to becoming a physician-scientist, along with some of our advances in beta cell biology.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Professor of Medicine, Chief, Division of Endocrinology, Diabetes and Metabolism, Director of Weill Center for Metabolic Health, Weill Cornell Medical College)

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso interacts with our interns.

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso began with a brief history of insulin discovery and then discussed a rewarding journey to becoming a physician-scientist. She further shared some exciting findings from her research on pancreatic beta-cell regeneration, involving unfolded protein response that may be involved in beta-cell replication. Dr. Alonso ended her session by sharing other ongoing projects in her lab and future directions to develop therapeutic tools; increasing stress to induce beta-cell replication, decreasing stress to save beta-cells from dying, and predicting stress-related diabetes risk to allow preventive intervention. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 5: Pancreatic Beta Cell Regeneration: Perspectives of a Physician-Scientist by Dr. Laura Alonso (Weill Cornell Medical College). Dr. Alonso addresses outstanding questions frow our interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina welcomes our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Type 1 diabetes occurs when the immune system becomes activated against the pancreatic β cells, leading to deficiency of the hormone insulin and chronically elevated blood glucose levels. Our research is focused on understanding the molecular pathways in the β cells that contribute to type 1 diabetes development, with the goal of targeting these pathways to help preserve insulin secretion in those with or at risk of type 1 diabetes.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Eli Lilly and Company Professor of Pediatric Diabetes, Professor of Pediatrics and Medicine, Director, IU Center for Diabetes and Metabolic Diseases, Diabetes Program Director, Herman B Wells Center for Pediatric Research, Director, Indiana DRC Islet & Physiology Core, Indiana University School of Medicine)

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Evans-Molina began with an introduction of the pathophysiology and natural history of type 1 diabetes. She then presented updated stages of type 1 diabetes during the disease progression, starting with the genetic risk and immune activation and response that leads to Stage 1 (normoglycemia with equal or more than 2 autoantibodies), Stage 2 (Dysglycemia with equal or more than 2 autoantibodies), and Stage 3 (Clinical Diagnosis). She discussed how this staging has facilitated early immune interventions. Dr. Evans-Molina also shared some exciting findings from clinical trials involving Tepluzimab as the first FDA-approved disease-modifying therapy for type 1 diabetes. She ended her session by presenting exciting future areas being explored by her lab for type 1 diabetes interventions that involve beta-cell ER stress and type 1 interferon to modulate autoimmunity and beta-cell stress. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Evans-Molina began with an introduction of the pathophysiology and natural history of type 1 diabetes. She then presented updated stages of type 1 diabetes during the disease progression, starting with the genetic risk and immune activation and response that leads to Stage 1 (normoglycemia with equal or more than 2 autoantibodies), Stage 2 (Dysglycemia with equal or more than 2 autoantibodies), and Stage 3 (Clinical Diagnosis). She discussed how this staging has facilitated early immune interventions. Dr. Evans-Molina also shared some exciting findings from clinical trials involving Tepluzimab as the first FDA-approved disease-modifying therapy for type 1 diabetes. She ended her session by presenting exciting future areas being explored by her lab for type 1 diabetes interventions that involve beta-cell ER stress and type 1 interferon to modulate autoimmunity and beta-cell stress. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Evans-Molina began with an introduction of the pathophysiology and natural history of type 1 diabetes. She then presented updated stages of type 1 diabetes during the disease progression, starting with the genetic risk and immune activation and response that leads to Stage 1 (normoglycemia with equal or more than 2 autoantibodies), Stage 2 (Dysglycemia with equal or more than 2 autoantibodies), and Stage 3 (Clinical Diagnosis). She discussed how this staging has facilitated early immune interventions. Dr. Evans-Molina also shared some exciting findings from clinical trials involving Tepluzimab as the first FDA-approved disease-modifying therapy for type 1 diabetes. She ended her session by presenting exciting future areas being explored by her lab for type 1 diabetes interventions that involve beta-cell ER stress and type 1 interferon to modulate autoimmunity and beta-cell stress. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Evans-Molina began with an introduction of the pathophysiology and natural history of type 1 diabetes. She then presented updated stages of type 1 diabetes during the disease progression, starting with the genetic risk and immune activation and response that leads to Stage 1 (normoglycemia with equal or more than 2 autoantibodies), Stage 2 (Dysglycemia with equal or more than 2 autoantibodies), and Stage 3 (Clinical Diagnosis). She discussed how this staging has facilitated early immune interventions. Dr. Evans-Molina also shared some exciting findings from clinical trials involving Tepluzimab as the first FDA-approved disease-modifying therapy for type 1 diabetes. She ended her session by presenting exciting future areas being explored by her lab for type 1 diabetes interventions that involve beta-cell ER stress and type 1 interferon to modulate autoimmunity and beta-cell stress. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Evans-Molina began with an introduction of the pathophysiology and natural history of type 1 diabetes. She then presented updated stages of type 1 diabetes during the disease progression, starting with the genetic risk and immune activation and response that leads to Stage 1 (normoglycemia with equal or more than 2 autoantibodies), Stage 2 (Dysglycemia with equal or more than 2 autoantibodies), and Stage 3 (Clinical Diagnosis). She discussed how this staging has facilitated early immune interventions. Dr. Evans-Molina also shared some exciting findings from clinical trials involving Tepluzimab as the first FDA-approved disease-modifying therapy for type 1 diabetes. She ended her session by presenting exciting future areas being explored by her lab for type 1 diabetes interventions that involve beta-cell ER stress and type 1 interferon to modulate autoimmunity and beta-cell stress. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina addresses outstanding questions frow our interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina interacts with our DVSC24 interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina addresses outstanding questions frow our interns.

Session 6: A Parallax View of Type 1 Diabetes by Dr. Carmella Evans-Molina (Indiana University School of Medicine). Dr. Carmella Evans-Molina addresses outstanding questions frow our interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School)
Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego).

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School)
Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego).

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni welcomes our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni welcomes our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Recent studies suggest that changes in the decoration of the mRNA molecule are important in metabolism. For example, they can directly regulate proteins to alter the ability of insulin-secreting cells to survive and/or to improve insulin secretion. How these changes play a role in the initiation and progression of diabetes will be discussed.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Diabetes Research and Wellness Foundation Endowed Chair and Professor of Medicine, Senior Investigator, co-Section Head of Islet & Regenerative Biology, and Associate Director of Diabetes Research Center, Joslin Diabetes Center, Harvard Medical School).

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni interacts with our DVSC24 interns.

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni began with an introduction to dynamic mRNA modifications, cellular pathways of m6A, and his lab’s focus on the role of m6A in metabolic organs. He then discussed how m6A-decorated genes in human islets with type 1 diabetes included disease-risk genes and how innate immune genes are upregulated in pancreatic islets during type 1 diabetes onset. Dr. Kulkarni ended the session with some exciting data showing the role of METTL3 in human islets, potentially responsible for anti-viral and innate immune response and beta-cell death. Throughout his presentation, Dr. Kulkarni gave several insightful tips for our future physicians and scientists: 1) Focus, 2) Be prepared for changes in your plans and adapt to changes, 3) Experience different labs, 4) Create your own path to get to where you want to be, and 5) Choose something you love to do! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 7: Role of mRNA Modifications in Diabetes by Dr. Rohit Kulkarni (Harvard Medical School). Dr. Kulkarni addresses outstanding questions from our interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel welcomes our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). This session will discuss how metabolically active cells control energy storage and utilization in response to hormones and nutrients in health and disease.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (Distinguished Professor of Medicine and PharmacologyDirector, Institute of Diabetes & Metabolic HealthDirector, UCSD/UCLA Diabetes Research CenterDr. Maryam Ahmadian Endowed Chair in Metabolic Health, University of California San Diego School of Medicine)

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel interacts with our DVSC24 interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel began with an introduction to how cells respond to metabolic stress in obesity and a paradox in the field that metabolic stress causes more energy storage and less energy expenditure. He then discussed his lab’s focus on the role of inflammation in cellular adaptation to metabolic stress and how glycogen and its key metabolic enzymes regulate adaptation to anabolic stress in obesity and catabolic stress in starvation. Dr. Saltiel ended the session with some exciting research on mitochondrial function in obesity and shared molecular signaling pathways affecting mitochondrial fission in white adipocytes that are altered in obesity. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel addresses outstanding questions from our interns.

Session 8: Adapting to Metabolic Stress by Dr. Alan Saltiel (University of California San Diego School of Medicine). Dr. Saltiel addresses outstanding questions from our interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School)
Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School)

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). When Banting and Best discovered insulin in 1921, they had no idea of what the molecule really was. Since that time, many other important researchers, including several who won the Nobel prize, have figured out what insulin is, and how to improve it for human therapy. It’s has been 50 years since the discovery of the insulin receptor, the first step in insulin signaling. We are still learning how this process works and what goes wrong and type two diabetes. These topics will be discussed during the session.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Mary K. Iacocca Professor of Medicine, Chief Academic Officer and Section Head of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School)

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 9: Insulin – 100 Years Old: Trying to Figure Out How It Works and How to Make It Better by Dr. C. Ronald Kahn (Harvard Medical School). Dr. Kahn began with a brief history of diabetes, the first 3,448 years, and a beautifully narrated story of insulin discovery by a group of physicians and scientists at the University of Toronto about 100 years ago and the early insulin treatments. Dr. Kahn presented a series of landmarks during insulin development for clinical use and his own landmark discovery of the insulin receptor tyrosine kinase in 1981, paving the next decades of significant discoveries in mapping insulin signal transduction. He ended such a visually engaging presentation by discussing insulin resistance at the core of type 2 diabetes and metabolic syndrome and major therapeutic challenges that still lie ahead to develop effective insulin-sensitizing drugs to treat type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School)

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Type 2 Diabetes (T2D) is a more aggressive disease when the onset is in youth compared with the onset in adulthood. This session will review the key findings from published multi-center clinical trials and observational studies including Treatment Options for Type 2 Diabetes in Youth (TODAY), the Search for Diabetes in Youth (SEARCH) study and the Restoring Insulin Secretion (RISE) study. This session will also provide an overview of approved pharmacologic therapies and strategies for managing T2D in youth.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka welcomes our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (Division Chief of Pediatric Endocrinology and Associate Professor of Pediatrics, UMass Memorial Health, University of Massachusetts Chan Medical School)

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka began with an introduction to type 2 diabetes in youth which has profoundly increased in incidence and prevalence in recent years and the rising burden of type 2 diabetes in youth. She discussed the pathophysiology of youth-onset type 2 diabetes and the important results from the RISE (Restoring Insulin Secretion) Study, showing the different effects of treatment with metformin and/or insulin glargine on glucose and C-peptide levels between youth and adults with type 2 diabetes. Dr. Soyka further discussed a prospective follow-up TODAY Study, showing how long-term diabetic complications involving nephropathy, hypertension, dyslipidemia, and neuropathy worsened in youth-onset type 2 diabetes compared to adults with type 2 diabetes, highlighting the increased severity and health outcomes in children with type 2 diabetes. Dr. Soyka ended her beautiful presentation by describing various goals to better treat youth-onset type 2 diabetes that included healthy lifestyle, public health policies to reduce obesogenic environment, and addressing social and mental determinants of health and discussed current medications for youth-onset type 2 diabetes, highlighting the need to find and approve more medications to treat type 2 diabetes in youth. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka interacts with our DVSC24 interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 10: Type 2 Diabetes in Youth: Differences from Adults by Dr. Leslie Soyka (University of Massachusetts Chan Medical School). Dr. Soyka addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)
Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School)

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay welcomes our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay welcomes our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). The field of diabetes research and care is vast. As I reflect on the nearly 40-year journey, I will share the drive to improve the lives of people affected by diabetes and maximize impact. It has been a journey from the micro to the macro. Along the way, you can see the many opportunities that being involved in the world of diabetes presents for your future career journeys.

Session 11: A Quest for Impact by Dr. Robert Gabbay (Chief Scientific and Medical Officer, American Diabetes Association, Associate Professor of Medicine, Harvard Medical School)

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay interacts with our DVSC24 interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay began with an interactive “word cloud,” asking our interns “What one or two words describe what will be the most impactful change in diabetes over the next 5 years?” as our interns used the chat box to enter their answers. Dr. Gabbay then shared a personal story of his own journey, the squiggly career, which was the basis of his recent TED talk that gave him the passion to treat from one patient to a population of people with diabetes. He shared insightful thoughts on different ways how one could impact diabetes, including by being a researcher, clinician, and educator, as well as engaging in improving care, digital health, leadership, health writer/content creator, entrepreneur, government policy, and public health. Dr. Gabbay ended his session by encouraging our interns to reach out and connect with those people who are doing such work and further advising our interns to combine what they are good at with what excites them. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School). Dr. Gabbay addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)
Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School)

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). This session will focus on how adipose (fat) cells can regulate insulin sensitivity, pancreatic beta cell mass, insulin secretion, and inflammation. We will discuss how these effects can be important for both Type 1 and Type 2 diabetes.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (George Richards Minot Professor of Medicine, Chief of Division of Endocrinology, Diabetes, and Metabolism, and Vice Chair for Research Strategy, Beth Israel Deaconess Medical Center, Harvard Medical School)

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn welcomes our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn interacts with our DVSC24 interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn began with an introduction to the significant 21st-century issue of the diabetes epidemic driven by the obesity epidemic and how we need to identify new molecular, cellular, and biochemical pathways underlying obesity and diabetes and better understand insulin action. She also introduced how white adipose tissue regulates whole-body metabolism by acting on lipid storage, energy balance, endocrine role, metabolic organs, and inflammation. Dr. Kahn then shared an exciting discovery of new lipids, 9-palmitic acid hydroxy stearic acids (PAHSAs) that are found in diets and synthesized by our adipose tissues. She summarized many important functions of PAHSAs, including regulation of glucose transport, insulin and GLP-1 secretion, hepatic glucose production, and inflammation. Dr. Kahn also presented some exciting data on PAHSA treatment that reduced innate and adaptive immunity in colitis and improved survival in a mouse model of type 1 diabetes (NOD mice) by affecting gene expression in pancreatic islets. She ended her session by discussing the biological activity of PAHSAs and the potential therapeutic role of such novel lipids in treating and preventing type 1 and type 2 diabetes. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School). Dr. Kahn addresses outstanding questions from our interns.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)
Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School)
Open Mic Session by Dr. Jason Kim, Dr. Barbara Kahn, Lauren Kim, and Allison Kim as interns are invited to ask questions in an open mic forum.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)
Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School)
Open Mic Session by Dr. Jason Kim, Dr. Barbara Kahn, Lauren Kim, and Allison Kim as interns are invited to ask questions in an open mic forum.

Session 11: A Quest for Impact by Dr. Robert Gabbay (American Diabetes Association and Harvard Medical School)
Session 12: Good Actions of Fat Cells to Prevent and Treat Diabetes by Dr. Barbara Kahn (Harvard Medical School)
Open Mic Session by Dr. Jason Kim, Dr. Barbara Kahn, Lauren Kim, and Allison Kim as interns are invited to ask questions in an open mic forum.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School)
Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School)
Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren & Allison Kim)

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session introduces the topic of obesity and its role in type 2 diabetes: why we are so prone to become obese and what may drive the current obesity pandemic, and hormonal regulation of body weight. The session further discusses how obesity is a major cause of type 2 diabetes, current paradigms explaining the molecular link, aging and diabetes, and the clash between diabetes and COVID-19 involving inflammation. The session ends with a discussion on lessons from the past on how we have failed to control obesity, and what we must do now and in future to prevent obesity and type 2 diabetes.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, Director of Metabolic Disease Research Center, MD/PhD Admissions Committee, University of Massachusetts Chan Medical School)

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim’s scientific presentation on the molecular link between obesity and type 2 diabetes began with an introduction to energy balance and the environmental, cultural, socioeconomic, and genetic factors contributing to the global obesity epidemic. He discussed the evolving paradigms on the link between fat and diabetes, paradox on diabetes in lipodystrophy, leptin action, and the importance of ectopic lipid accumulation on insulin resistance. He then discussed the role of inflammation in obesity and type 2 diabetes and shared his research findings on the protective effects of anti-inflammatory cytokine IL-10 on obesity-mediated and aging-associated insulin resistance and how poor maternal diet and excess weight gain during pregnancy may affect the metabolic health of offspring in later ages. Dr. Kim ended his presentation by sharing his latest research findings on the important role of macrophage IFN signaling and IL-12 on insulin resistance in the liver and metabolic liver disease. This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses outstanding questions from our interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses outstanding questions from our interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses outstanding questions from our interns.

Session 13: Obesity & Type 2 Diabetes: Marriage Made in Clinic by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses outstanding questions from our interns.

We are grateful to the American Diabetes Association and The Leona M. and Harry B. Helmsley Charitable Trust for their support of the Diabetes Virtual Camp!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our DVSC24 interns.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). This session introduces how high school and college students can explore their interests in science and medicine, and how college curriculum and extracurricular activities can be organized to prepare for medical school and graduate school. The session further presents a bird’s-eye view of the medical school and graduate school admissions process. The session ends with a discussion on what to expect and what challenges lie ahead in a winding path to a career in academic medicine and research, and the passion and service that define this lifelong profession.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim welcomes our DVSC24 interns.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, Director of Metabolic Disease Research Center, MD/PhD Admissions Committee, University of Massachusetts Chan Medical School)

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim interacts with our DVSC24 interns.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). Dr. Kim addresses outstanding questions from our interns.

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

Session 14: Preparing for a Career in Science and Medicine by Dr. Jason Kim (University of Massachusetts Chan Medical School). For high school, undergraduate, and post-bac students, Dr. Kim began with why medical school is a great option for anyone with a passion for science, medicine, and service and discussed what high school and college students can do to prepare for medical schools. He then discussed the medical school application process and the Medical Scientist Training Program. For medical students and residents, Dr. Kim presented a curriculum for the gastroenterology and hepatology training program at the University of Massachusetts Chan Medical School as an example of clinical fellowship. For fellows, postdocs, and junior faculty, Dr. Kim provided insights to a tenure-track faculty search at an academic institution and what characteristics and attributes we look for in new faculty. For fellows, postdocs, junior faculty, and early-career investigators, Dr. Kim discussed the professorship in academic medicine with regards to the tenure process and promotion to full professorship and further presented what a day in the life of an academic professor would look like, engaging in administrative committees, teaching and mentoring, national and international conferences and committees, and research. He highlighted a benchmark for a productive research program. Dr. Kim ended the session by sharing how the University of Massachusetts Chan Medical School excels in patient care, research, and education, his diabetes and metabolic disease research program at the Albert Sherman Center, and why being a professor and a scientist is the best job in the world! This was followed by a highly stimulating Q&A period from our interns. Truly incredible and engaging sessions at DVSC24!

We are grateful to the American Diabetes Association and The Leona M. and Harry B. Helmsley Charitable Trust for their support of the Diabetes Virtual Camp!

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The Closing Session summarizes the program and the process of receiving a program certificate, collects attendee evaluations and polls, and discusses future opportunities.

Session 15: Closing Session by Diabetes Virtual Camp Team
Lauren Kim (Founder, Program Director, and Webmaster, University of Southern California, B.S. in Human Biology, 24’)
Allison Kim (Associate Director and Director of Outreach, Boston University, B.A. in Biology, 23’)
Dr. Jason Kim (Professor of Molecular Medicine and Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, Director of Metabolic Disease Research Center, MD/PhD Admissions Committee, University of Massachusetts Chan Medical School)

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team welcomes our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team welcomes our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team welcomes our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim)
After 15 exciting sessions of the Diabetes Virtual Summer Camp 2024, we arrived at the Closing Session with Lauren Kim (Founder, Program Director, and Webmaster), Allison Kim (Associate Director and Director of Outreach), and Dr. Jason Kim (Advisor). Lauren began with a heartfelt appreciation to the DVSC24 interns for their steadfast interest and growing passion for diabetes research, education, and care. Our interns asked outstanding questions using the Chat box after every sessions, demonstrating inquisitive minds and further showed tremendous dedication for this virtual internship as those interns from Asia stayed up well past midnight for our sessions. Dr. Kim explained the process of requesting a program certificate for the Diabetes Virtual Summer Camp 2024. The Diabetes Virtual Camp Team then administered electronic polls and surveys to obtain important feedback from the interns about our program and explained the final program task to be completed within a week. We also held an open mic session where the interns were unmuted to directly ask questions and provide more feedback on our program. The Closing Session ended with the final farewells to everyone as we remain hopeful that our program has met the goals to supporting the next generation of physicians and scientists and one day finding a cure for diabetes. The Diabetes Virtual Camp looks forward to seeing you all in 2025!

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team interacts with our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). Open Mic Session by Lauren Kim, Allison Kim, and Dr. Jason Kim as interns are invited to ask questions in an open mic forum.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). Open Mic Session by Lauren Kim, Allison Kim, and Dr. Jason Kim as interns are invited to ask questions in an open mic forum.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). Open Mic Session by Lauren Kim, Allison Kim, and Dr. Jason Kim as interns are invited to ask questions in an open mic forum.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The DVC Team says “goodbyes” to our DVSC24 interns.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). Open Mic Session by Lauren Kim, Allison Kim, and Dr. Jason Kim as interns are invited to ask questions in an open mic forum.

Session 15: Closing Session by Diabetes Virtual Camp Team (Lauren Kim, Allison Kim, and Dr. Jason Kim). The Diabetes Virtual Camp looks forward to seeing you all in 2025!